Unit News

Showing items through of articles.
  • WVU researcher seeks vaccine to prevent lethal pneumonia

    Tuesday, November 20, 2018

    About half of all people with cystic fibrosis, the most common genetic disorder in the United States, die from a lung disease before they turn 40. A form of pneumonia called Pseudomonas aeruginosa is a likely culprit. These bacteria have become so hard to treat that the Centers for Disease Control deemed it a serious threat to the nation.

    Read WVU researcher seeks vaccine to prevent lethal pneumonia full story

  • Alumnus gives $1 million to WVU Department of Neurology for patient support

    Monday, November 19, 2018

    Michael T. Escue, a native of Point Pleasant, has committed $1 million to West Virginia University to establish the Ronald E. & Jo Ann Reynolds Escue Neurology Endowment named for his parents. 

    Read Alumnus gives $1 million to WVU Department of Neurology for patient support full story

  • New training model mimics real-world surgery for WVU residents

    Friday, November 16, 2018

    Instinct— surgeons act on it in the operating room, but it can be difficult-- though not impossible-- to teach, thanks to a perfused cadaver training model at the West Virginia University School of Medicine that mimics real-world surgery conditions.

    Read New training model mimics real-world surgery for WVU residents full story

  • Stop the Bleed

    Friday, November 16, 2018

    The Jon Michael Moore Trauma Center, in partnership with the American College of Surgeons, is taking part in the national “Stop the Bleed” initiative. Participants in the programs are being trained to stop bleeding in order to prevent death from hemorrhage.

    Read Stop the Bleed full story

  • West Virginia University first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain

    Thursday, November 15, 2018

    As part of an ongoing commitment to battle opioid addiction, the Rockefeller Neuroscience Institute (RNI) at West Virginia University today (Nov. 15) marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.

    Read West Virginia University first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain full story